Reports for TEVA-ABACAVIR/LAMIVUDINE
Brand name TEVA-ABACAVIR/LAMIVUDINE |
|---|
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02416662 |
Ingredients
ABACAVIR LAMIVUDINE |
Ingredient Strength
600 MG 300 MG |
ATC Code
J05AR |
ATC Descriptor
DIRECT ACTING ANTIVIRALS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-ABACAVIR/LAMIVUDINE | 30 | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
| TEVA-ABACAVIR/LAMIVUDINE | 100 | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
| TEVA-ABACAVIR/LAMIVUDINE | 100, 30 | Resolved | 2023-06-08 | 2023-07-05 | 194180 |
| TEVA-ABACAVIR/LAMIVUDINE | 100 | Resolved | 2023-06-16 | 2023-08-17 | 195072 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
| TEVA-ABACAVIR/LAMIVUDINE | ALL | Actual shortage | 2025-01-30 | 2025-01-30 | 249179 |
Showing 1 to 6 of 6
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0